Alps Advisors Inc Intercept Pharmaceuticals, Inc. Transaction History

Alps Advisors Inc

$14.8 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$9.99 - $18.71 $2,347 - $4,396	235 Added 0.77%	30,878 $572,000
Q2 2023 Aug 14, 2023	BUY	$9.17 - $19.29 $29,233 - $61,496	3,188 Added 11.61%	30,643 $338,000
Q1 2023 May 10, 2023	SELL	$12.53 - $21.71 $8,545 - $14,806	-682 Reduced 2.42%	27,455 $368,000
Q4 2022 Feb 14, 2023	BUY	$11.61 - $16.11 $138,251 - $191,837	11,908 Added 73.37%	28,137 $348,000
Q3 2022 Nov 14, 2022	SELL	$12.21 - $19.7 $17,142 - $27,658	-1,404 Reduced 7.96%	16,229 $226,000
Q2 2022 Aug 11, 2022	SELL	$11.23 - $19.59 $144,664 - $252,358	-12,882 Reduced 42.22%	17,633 $244,000
Q1 2022 May 16, 2022	SELL	$13.37 - $17.79 $49,188 - $65,449	-3,679 Reduced 10.76%	30,515 $496,000
Q4 2021 Feb 09, 2022	SELL	$14.28 - $19.53 $92,748 - $126,847	-6,495 Reduced 15.96%	34,194 $557,000
Q3 2021 Nov 15, 2021	SELL	$12.99 - $20.47 $38,853 - $61,225	-2,991 Reduced 6.85%	40,689 $604,000
Q2 2021 Aug 11, 2021	SELL	$15.46 - $24.5 $248,210 - $393,347	-16,055 Reduced 26.88%	43,680 $872,000
Q1 2021 May 07, 2021	BUY	$19.33 - $37.75 $2,338 - $4,567	121 Added 0.2%	59,735 $1.38 Million
Q4 2020 Feb 03, 2021	BUY	$24.48 - $42.47 $429,795 - $745,645	17,557 Added 41.75%	59,614 $1.47 Million
Q3 2020 Nov 04, 2020	SELL	$39.09 - $53.44 $112,422 - $153,693	-2,876 Reduced 6.4%	42,057 $1.74 Million
Q2 2020 Aug 05, 2020	SELL	$46.7 - $92.04 $680,792 - $1.34 Million	-14,578 Reduced 24.5%	44,933 $2.15 Million
Q1 2020 May 06, 2020	SELL	$48.35 - $118.68 $311,228 - $763,943	-6,437 Reduced 9.76%	59,511 $3.75 Million
Q4 2019 Feb 07, 2020	BUY	$57.36 - $124.1 $3.78 Million - $8.18 Million	65,948 New	65,948 $8.17 Million
Q4 2018 Feb 04, 2019	SELL	$85.79 - $126.46 $4.49 Million - $6.62 Million	-52,318 Closed	0 $0
Q3 2018 Oct 25, 2018	BUY	$88.49 - $127.55 $872,865 - $1.26 Million	9,864 Added 23.23%	52,318 $6.61 Million
Q2 2018 Aug 02, 2018	BUY	$60.0 - $85.67 $2.55 Million - $3.64 Million	42,454 New	42,454 $3.56 Million
Q4 2017 Feb 05, 2018	SELL	$58.2 - $72.76 $1.44 Million - $1.8 Million	-24,720 Closed	0 $0
Q3 2017 Nov 03, 2017	BUY	$57.01 - $118.75 $1.41 Million - $2.94 Million	24,720	24,720 $1.44 Million

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account